20 - 21 March 2018 | London, UK

The recent PPMA event in London (21-22 March 2018) addressed some of the most important market access challenges that health care systems and pharma are facing nowadays and, adding to the impact, was well attended by a good representation from payers, pharma and biotech companies, patient representatives and Academia. The agenda included the ‘classic’ topics about HTA and pricing, but also well covered the disruptive changes associated with advanced therapies such as immune-oncology, drugs for rare diseases, and digital technologies/big data.

PW presented their insight into world-wide market access for rare disease therapies, and what the way forward could look like and facilitated a round table around the learning from cell and gene therapies (a ‘lens’ into the future).

Click here to view our presentation, presented by Francois Lucas.

Share